Achilles Therapeutics plc (ACHL) Tops Q3 EPS by 27c
Tweet
Share
E-mailGet Alerts ACHL Hot Sheet
Join SI Premium – FREE
Achilles Therapeutics plc (NASDAQ: ACHL) reported Q3 EPS of ($0.32), $0.27 better than the analyst estimate of ($0.59).
For earnings history and earnings-related data on Achilles Therapeutics plc (ACHL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
- Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
